01
Cash & equivalents increased 216.6%
Cash & equivalents changed +216.6% from the comparable as-filed period.
$10.7M→$34.0MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTCOGNITION THERAPEUTICS INC's latest supported as-filed period reports interest income of -$3,000. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +216.6% from the comparable as-filed period.
Net income changed +41.6% from the comparable as-filed period.
Operating income changed +44.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CGTX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-092362SEC ↗8-KAug 6, 2026Period Aug 6, 20260001104659-26-092037SEC ↗8-KJun 24, 2026Period Jun 24, 20260001104659-26-077060SEC ↗4Jun 22, 2026Period Jun 17, 20260001104659-26-076477SEC ↗4Jun 22, 2026Period Jun 17, 20260001104659-26-076475SEC ↗4Jun 22, 2026Period Jun 17, 20260001104659-26-076472SEC ↗4Jun 22, 2026Period Jun 17, 20260001104659-26-076470SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 17, 2026Filed Jun 22, 2026 | Khattar Jack A.Director | Grant Or AwardDirect | 25,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -55.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed -48.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001789490-26-000002